Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2022 Jun 22;10(7):1480. doi: 10.3390/biomedicines10071480

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2022 by the authors.

Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).

PMC Copyright notice

Progress of pulmonary function tests. Figure 3 shows the data for the pulmonary function tests at diagnosis of ILD, at the baseline visit (V0), at 12 months (V12), and at the final visit (FV): (A) forced vital capacity; (B) forced expiratory volume in the first second, (C) diffusing capacity of the lung for carbon monoxide. The p value for baseline (V0) is the result of comparing values between V0 and the date of diagnosis of ILD. The p value for 12 months (V12) and at the end of follow-up (FV) is the result of the comparison between V12 and FV and baseline (V0). The median (IQR) follow-up time was 27.3 (12.2–42.8) months.

Progress of pulmonary function tests. Figure 3 shows the data for the pulmonary function tests at diagnosis of ILD, at the baseline visit (V0), at 12 months (V12), and at the final visit (FV): (A) forced vital capacity; (B) forced expiratory volume in the first second, (C) diffusing capacity of the lung for carbon monoxide. The p value for baseline (V0) is the result of comparing values between V0 and the date of diagnosis of ILD. The p value for 12 months (V12) and at the end of follow-up (FV) is the result of the comparison between V12 and FV and baseline (V0). The median (IQR) follow-up time was 27.3 (12.2–42.8) months.